Kaushal Mohit 4/A
4/A · Oncology Institute, Inc. · Filed Nov 18, 2021
Insider Transaction Report
Form 4/AAmended
Kaushal Mohit
Director
Transactions
- Exercise/Conversion
Common Stock
2021-11-12+30,000→ 30,000 total - Exercise/Conversion
Class B Common Stock
2021-11-12−30,000→ 0 total→ Class A Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date.
- [F2]On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination. In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7.